Search results for "reparations"

showing 10 items of 367 documents

Different Dissolution Media Lead to Different Crystal Structures of Talinolol with Impact on Its Dissolution and Solubility

2003

During the performance of dissolution tests with immediate and controlled-release talinolol tablets it was detected that the type of the buffer used as dissolution medium had a strong influence on the solubility and the dissolution behavior of the drug. It was proven that talinolol appeared in different crystal structures with strongly differing solubilities when pure water, acetate, or phosphate buffers were employed as dissolution media. The resulting crystal structures were characterized by means of light microscopy, differential scanning calorimetry, and X-ray powder diffraction. All methods were adjuvant to detect changes in talinolol crystal structures. The different solubility and di…

Surface PropertiesSodiumAdrenergic beta-AntagonistsPharmaceutical Sciencechemistry.chemical_elementSodium ChlorideDosage formlaw.inventionPropanolamineschemistry.chemical_compoundX-Ray DiffractionPulmonary surfactantlawDrug DiscoverySolubilityCrystallizationDissolutionPharmacologyChromatographyCalorimetry Differential ScanningChemistryOsmolar ConcentrationOrganic ChemistryHydrogen-Ion ConcentrationSolubilityIonic strengthDelayed-Action PreparationsSolventsCrystallizationTalinololNuclear chemistryDrug Development and Industrial Pharmacy
researchProduct

Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy.

2010

Drugs derived from natural resources represent a significant segment of the pharmaceutical market as compared to randomly synthesized compounds. It is a goal of drug development programs to design selective ligands that act on single disease targets to obtain highly effective and safe drugs with low side effects. Although this strategy was successful for many new therapies, there is a marked decline in the number of new drugs introduced into clinical practice over the past decades. One reason for this failure may be due to the fact that the pathogenesis of many diseases is rather multi-factorial in nature and not due to a single cause. Phytotherapy, whose therapeutic efficacy is based on th…

Systems biologyClinical BiochemistryPharmaceutical marketHerb-Drug InteractionsPharmacologylaw.inventionMulti targetlawDrug DiscoveryOils VolatileAnimalsHumansDrug InteractionsPharmacologyChemistryPlant ExtractsDrug SynergismPlantsClinical PracticeDrug developmentMolecular MedicinePlant PreparationsPhytotherapySignalling cascadesFunction (biology)PhytotherapyCurrent drug targets
researchProduct

The role of the dual nature of ionic liquids in the reversed-phase liquid chromatographic separation of basic drugs.

2010

The cationic nature of basic drugs gives rise to broad asymmetrical chromatographic peaks with conventional C18 columns and hydro-organic mixtures, due to the ionic interaction of the positively charged solutes with the free silanol groups on the alkyl-bonded reversed-phase packing. Ionic liquids (ILs) have recently attracted some attention to reduce this undesirable silanol activity. ILs are dual modifiers (with a cationic and anionic character), which means that both cation and anion can be adsorbed on the stationary phase, giving rise to interesting interactions with the anionic free silanols and the cationic basic drugs. A comparative study of the performance of four imidazolium-based I…

TetrafluoroborateIonic bondingIonic LiquidsBiochemistryAnalytical Chemistrychemistry.chemical_compoundPhase (matter)BoratesEthylaminesTriethylamineChromatography Reverse-PhaseChromatographyOrganic ChemistryCationic polymerizationImidazolesSodium Dodecyl SulfateGeneral MedicineReversed-phase chromatographyHydrogen-Ion ConcentrationSilanesSilanolchemistryModels ChemicalPharmaceutical PreparationsIonic liquidLinear ModelsJournal of chromatography. A
researchProduct

PHEA-graft-polybutylmethacrylate copolymer microparticles for delivery of hydrophobic drugs.

2012

Abstract Polymeric microparticles encapsulating two model hydrophobic drugs, beclomethasone dipropionate (BDP) and flutamide (FLU) were prepared by using the high pressure homogenization-solvent evaporation method starting from a oil-in-water emulsion. For the preparation of polymeric microparticles a α,β-poly(N-2-hydroxyethyl)- d , l -aspartamide (PHEA) graft copolymer with comb like structure was properly synthesized via grafting from atom transfer radical polymerization (ATRP) technique, by using two subsequent synthetic steps. In the first step a polymeric multifunctional macroinitiator was obtained by the conjugation of a proper number of 2-bromoisobutyryl bromide (BIB) residues to the…

Time FactorsBioadhesivePharmaceutical ScienceCell LineDrug Delivery SystemsPolymethacrylic AcidsPolymer chemistryMucoadhesionCopolymerSide chainHumansPhea polybutylmethacrylate microparticles drug deliveryParticle SizeGlucocorticoidsDrug CarriersDose-Response Relationship DrugChemistryAtom-transfer radical-polymerizationBeclomethasoneAdhesivenessAndrogen AntagonistsGraftingFlutamideMicrospheresPolymerizationDelayed-Action PreparationsEmulsionSolventsNanoparticlesEmulsionsCaco-2 CellsPeptidesHydrophobic and Hydrophilic InteractionsInternational journal of pharmaceutics
researchProduct

SYNTHESIS, CHARACTERIZATION AND IN VITRO CYTOTOXICITY STUDIES OF A MACROMOLECULAR CONJUGATE OF PACLITAXEL BEARING OXYTOCIN AS TARGETING MOIETY.

2007

The present study describes the experimental synthetic procedure and the characterization of a new polyaspartamide macromolecular prodrug of paclitaxel, bearing oxytocin residues as targeting moieties. In vitro stability studies of bioconjugate, performed in media mimicking biological fluids (buffer solutions at pH 7.4 and 5.5) and in human plasma, evidenced the high stability of the targeting portion (oxytocin)-polymer linkage and the ability of this conjugate to release linked paclitaxel in a prolonged way in plasma. Moreover, preliminary in vitro antiproliferative studies, carried out on MCF-7 cells, that are oxytocin receptor positive cells, showed that the polymeric conjugate has the s…

Time FactorsChemistry PharmaceuticalDrug CompoundingpolyaspartamidePharmaceutical ScienceBreast NeoplasmsPolyethylene Glycolschemistry.chemical_compoundpaclitaxelDrug StabilityCell Line TumoroxytocinHumansMoietyProdrugsbioconjugateCytotoxicityCell ProliferationDrug CarriersDose-Response Relationship DrugMolecular StructureHydrolysisdrug targetingGeneral MedicineHydrogen-Ion ConcentrationAntineoplastic Agents PhytogenicOxytocin receptorIn vitroSolubilityPaclitaxelchemistryBiochemistryTargeted drug deliveryReceptors OxytocinDelayed-Action PreparationsFemalePeptidesDrug carrierBiotechnologyConjugate
researchProduct

Prostaglandin E(2)-loaded microspheres as strategy to inhibit phagocytosis and modulate inflammatory mediators release.

2008

PGE(2), an arachidonic acid metabolite produced by various type of cells regulates a broad range of physiological activities in the endocrine, cardiovascular, gastrointestinal, and immune systems, and is involved in maintaining the local homeostasis. In the immune system, PGE(2) is mainly produced by APCs and it can suppress the Th1-mediated immune responses. The aim of this study was to develop PGE(2)-loaded biodegradable MS that prolong and sustain the in vivo release of this mediator. An o/w emulsion solvent extraction-evaporation method was chosen to prepare the MS. We determined their diameters, evaluated the in vitro release of PGE(2), using enzyme immunoassay and MS uptake by periton…

Time Factorsmedicine.medical_treatmentPhagocytosisChemistry PharmaceuticalDrug CompoundingPharmaceutical ScienceInflammationPharmacologyBiologyNitric OxideDinoprostonechemistry.chemical_compoundMiceImmune systemPhagocytosisIn vivoSepsismedicineAnimalsHumansImmunologic FactorsProstaglandin E2Particle SizeCells CulturedChemokine CCL2Tumor Necrosis Factor-alphaEndothelial CellsWaterGeneral MedicineMicrospheresDisease Models AnimalchemistryBiochemistrySolubilityDelayed-Action PreparationsMacrophages PeritonealLiberationlipids (amino acids peptides and proteins)Arachidonic acidEmulsionsmedicine.symptomInflammation MediatorsOilsBiotechnologyProstaglandin Emedicine.drugEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
researchProduct

Time-Gated Raman Spectroscopy for Quantitative Determination of Solid-State Forms of Fluorescent Pharmaceuticals

2018

Raman spectroscopy is widely used for quantitative pharmaceutical analysis, but a common obstacle to its use is sample fluorescence masking the Raman signal. Time-gating provides an instrument-based method for rejecting fluorescence through temporal resolution of the spectral signal and allows Raman spectra of fluorescent materials to be obtained. An additional practical advantage is that analysis is possible in ambient lighting. This study assesses the efficacy of time-gated Raman spectroscopy for the quantitative measurement of fluorescent pharmaceuticals. Time-gated Raman spectroscopy with a 128 X (2) X 4 CMOS SPAD detector was applied for quantitative analysis of ternary mixtures of sol…

Time Factorsspektroskopia116 Chemical sciencesAnalytical chemistry02 engineering and technologySpectrum Analysis Raman01 natural sciencesSignalAnalytical Chemistrysymbols.namesakeTime domainLeast-Squares Analysista116DETECTORFluorescent DyesSUPPRESSIONta113ta114Chemistry010401 analytical chemistryDetectorMIXTURESSENSORPIROXICAMRESONANCE021001 nanoscience & nanotechnologyRAY-POWDER DIFFRACTIONFluorescence0104 chemical sciencesSPADPharmaceutical PreparationsPHOTON AVALANCHE-DIODETemporal resolutionRaman spectroscopysymbolsCRYSTALLIZATION0210 nano-technologyRaman spectroscopyTernary operationQuantitative analysis (chemistry)
researchProduct

Nano into Micro Formulations of Tobramycin for the Treatment of Pseudomonas aeruginosa Infections in Cystic Fibrosis.

2017

Here, nano into micro formulations (NiMs) of tobramycin for the treatment of Pseudomonas aeruginosa airway infections in cystic fibrosis (CF) are described. NiMs were produced by spray drying a solution containing polymers or sugars and a nanometric polyanion–tobramcyin complex (PTC), able to achieve a prolonged antibiotic release. NiMs properties were compared to TOBIPodhaler(Novartis), the only one commercially available dry powder inhalatory formulation based on porous microparticles. Produced NiMs showed adequate characteristics for pulmonary administration, as spherical shape, micrometric size, and high cytocompatibility toward human bronchial epithelial cells. Contrarily to TOBIPodhal…

Tobramycin Cystic Fibrosis Artificial Mucus (CF-AM) αβ-poly-(N-2-hydroxyethyl)-DL-aspartamide (PHEA) ion pair complex nano into micro strategy Pseudomonas aeruginosa infections biofilmPolymers and PlasticsCystic FibrosisPolymersChemistry PharmaceuticalBioengineeringBronchi02 engineering and technologymedicine.disease_causeCystic fibrosisMicrobiologyBiomaterials03 medical and health sciences0302 clinical medicineDrug Delivery SystemsNano-Materials ChemistrymedicineTobramycinHumansPseudomonas InfectionsParticle SizeRespiratory Tract InfectionsCells CulturedDrug CarriersPseudomonas aeruginosaChemistryBiofilmDry Powder InhalersEpithelial Cells021001 nanoscience & nanotechnologyAntimicrobialmedicine.diseaseMucusPolyelectrolytesAnti-Bacterial Agents030228 respiratory systemSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoSpray dryingBiofilmsDelayed-Action PreparationsPseudomonas aeruginosaTobramycinNanoparticles0210 nano-technologymedicine.drugBiomacromolecules
researchProduct

Vertical distribution of pharmaceuticals in lake sediments-citalopram as potential chemomarker

2012

The use of pharmaceuticals has increased enormously over the last few decades and serious concerns about their environmental fate and effects have arisen. Thus far, there is little knowledge about the historical pollution of the environment by pharmaceuticals. In the present study, sediment columns from three lake sites adjacent to wastewater treatment plants were collected, further divided in 2- or 2.5-cm slices, and analyzed for 15 pharmaceuticals by liquid chromatography-tandem mass spectrometry. In addition, sediment columns were historically interpreted by analyzing fecal sterols (coprostanol and cholesterol) as well as organic material and organic carbon. Several pharmaceuticals were …

Total organic carbonPollutionGeologic SedimentsHealth Toxicology and Mutagenesismedia_common.quotation_subjectSedimentCitalopramContaminationCholestanolCoprostanolLakesSterolschemistry.chemical_compoundPharmaceutical PreparationschemistryWastewaterEnvironmental chemistryEnvironmental ChemistryEnvironmental scienceSewage treatmentEffluentWater Pollutants ChemicalEnvironmental Monitoringmedia_commonEnvironmental Toxicology and Chemistry
researchProduct

Phytoestrogens increase the capacity of serum to stimulate prostacyclin release in human endothelial cells

2003

Both the estrogen receptor (ER) alpha and beta isoforms are expressed in the endothelium. The ER beta has been assigned a crucial role in normal vascular wall function. Prostacyclin has been ascribed a beneficial effect on vessel wall physiology. Isoflavones bind with higher affinity to ER beta. We investigated the hypothesis that their administration to postmenopausal women can promote endothelial prostacyclin production.Twenty-five healthy postmenopausal women with mild climacteric symptoms received capsules containing 55 mg/day isoflavones derived from soy and red clover for 6 months. Cultured human umbilical vein endothelial cells (HUVECs) were exposed for 24 h to serum collected before…

Umbilical Veinsmedicine.medical_specialtyTime FactorsEndotheliumAdministration OralAlpha (ethology)Estrogen receptorPhytoestrogensProstacyclinDrug Administration ScheduleUmbilical veinchemistry.chemical_compoundInternal medicinemedicineHumansEstrogens Non-SteroidalEstrogen receptor betaPlant Extractsbusiness.industryObstetrics and GynecologyGeneral MedicineMiddle AgedIsoflavonesBlood Physiological PhenomenaEpoprostenolIsoflavonesPostmenopauseEndocrinologymedicine.anatomical_structurechemistryFemaleTrifoliumPhytoestrogensEndothelium VascularPlant PreparationsSoybeansbusinessPlatelet Aggregation Inhibitorsmedicine.drugActa Obstetricia et Gynecologica Scandinavica
researchProduct